Central nervous system (CNS)-3D brain organoids neuropharmacological analysis EO 14398
Active Purchase Order Awarded Last action
- Contract number
- 75F40126P00150
- Awardee
-
28Bio, Inc. UEI RT13MNMRHL33
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $143,021
Award facts
- Opportunity
-
- CNS Organoid Neuropharmacological Analysis Pre-Solicitation · 75F40126Q134171 · Posted Apr 24, 2026
- Contract value 100% obligated
- $143,020.98 Current and potential, with all options
- Completion date 35% complete
- Current and potential, with all options
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Metairie, LA 70006, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to 28Bio, Inc. for Central Nervous System 3D brain organoids neuropharmacological analysis valued at $143,020.98, with an award date of August 1, 2026. Performance is located in Metairie, Louisiana and extends through April 30, 2027. The order calls for functional examination of neuromodulatory effects of a marketed small molecule drug using human CNS 3D brain organoids, including characterization of acute and chronic effects through calcium flux measurements, evaluation of 5-HT5A receptor involvement via co-treatment studies, viability assessments via LDH assays, and RNA sequencing to assess transcriptional changes following chronic drug exposure. Testing uses 28Bio organoids at 10 weeks of differentiation across 10 treatment groups with 32 organoids per group. Deliverables include final study design within one month of award, acute and chronic neuromodulatory effects data by January 31, 2027, and transcriptomic data by March 31, 2027. The order originated from a pre-solicitation notice posted April 24, 2026.
Quick answers
Who was awarded contract 75F40126P00150?
75F40126P00150 was awarded to 28Bio, Inc. by Food and Drug Administration (Department of Health and Human Services) on August 1, 2026.
How much is contract 75F40126P00150 worth?
The government has obligated $143,021 on 75F40126P00150.
Was contract 75F40126P00150 competed?
The extent of competition for 75F40126P00150 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award